Skip to main content
Contact Us
Subscribe
E-Edition
76°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Senseonics Holdings
(NY:
SENS
)
0.4698
+0.0008 (+0.17%)
Official Closing Price
Updated: 8:00 PM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Senseonics Holdings
< Previous
1
2
3
Next >
Senseonics Holdings, Inc. and PHC Holdings Corporation To Host Joint Eversense CGM Virtual Analyst and Investor Event on March 15, 2023
February 17, 2023
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics Announces Equity Grants To Employees Under Inducement Plan
January 05, 2023
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics to Present at the Stifel 2022 Healthcare Conference
November 09, 2022
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics Holdings, Inc. Reports Third Quarter 2022 Financial Results
November 08, 2022
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics and Ascensia Announce a Collaboration with the Nurse Practitioner Group Designed to Expand Patient Access by Providing In-Office and At-Home Insertion Options for Eversense® E3 Continuous Glucose Monitoring System (CGM)
November 03, 2022
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics Holdings, Inc. Schedules Third Quarter 2022 Earnings Release and Conference Call for November 8, 2022, at 4:30 p.m. Eastern Time
October 25, 2022
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics Announces Equity Grants To Employees Under Inducement Plan
October 06, 2022
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
September 07, 2022
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics Announces CFO Transition
September 01, 2022
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
August 17, 2022
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics Holdings, Inc. Reports Second Quarter 2022 Financial Results
August 09, 2022
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics Announces a Positive Coverage Decision for Eversense® E3 CGM from Anthem
August 03, 2022
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics Holdings, Inc. Schedules Second Quarter 2022 Earnings Release and Conference Call for August 9, 2022, at 4:30 p.m. Eastern Time
July 26, 2022
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics Announces Equity Grants To Employees Under Inducement Plan
July 05, 2022
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics Announces CE Mark Approval of the Eversense E3 Continuous Glucose Monitoring System
June 16, 2022
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics to Participate in the Jefferies Healthcare Conference
May 26, 2022
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics to Participate in the H.C. Wainwright Global Investment Conference
May 16, 2022
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics Holdings, Inc. Reports First Quarter 2022 Financial Results
May 10, 2022
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics Holdings, Inc. Schedules First Quarter 2022 Earnings Release and Conference Call for May 10, 2022, at 4:30 p.m. Eastern Time
April 26, 2022
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics Announces the First Patient Implant of the Eversense E3 CGM System in the U.S.
April 06, 2022
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics Announces Equity Grants to Employees Under Inducement Plan
April 01, 2022
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call for March 1, 2022, at 4:30 p.m. Eastern Time
February 15, 2022
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics Announces FDA Approval of the Eversense® E3 Continuous Glucose Monitoring System for Use for Up to 6 months; Provides 2022 Business Outlook
February 11, 2022
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics Announces Equity Grants To Employees Under Inducement Plan
January 05, 2022
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics Announces Business Updates
January 04, 2022
From
Senseonics Holdings, Inc.
Via
Business Wire
Eversense NOW Remote Monitoring App for Android Users Receives CE Mark in Europe
December 21, 2021
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics Holdings, Inc. Reports Third Quarter 2021 Financial Results
November 09, 2021
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics to Participate in Upcoming November Investor Conferences
November 08, 2021
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics Holdings, Inc. Schedules Third Quarter 2021 Earnings Release and Conference Call for November 9, 2021, at 4:30 p.m. Eastern Time
October 26, 2021
From
Senseonics Holdings, Inc.
Via
Business Wire
Senseonics Announces Equity Grants To Employees Under Inducement Plan
October 04, 2021
From
Senseonics Holdings, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.